These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8566114)

  • 21. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
    Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
    Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of YM060 on 5-HT3 receptor-mediated depolarization in colonic myenteric neurons of the guinea pig.
    Ito H; Tamura K
    Eur J Pharmacol; 1995 Sep; 283(1-3):107-12. PubMed ID: 7498299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
    Boess FG; Riemer C; Bös M; Bentley J; Bourson A; Sleight AJ
    Mol Pharmacol; 1998 Sep; 54(3):577-83. PubMed ID: 9730917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
    Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM
    J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. IV. Synthesis and pharmacological evaluation of the oxidation products of (-)-(R)-5-[(1-methyl-1H-indol-3-yl)carbonyl] -4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride (YM060: ramosetron).
    Ohta M; Suzuki T; Nagashima S; Tokunaga T; Miyata K; Mase T
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1717-22. PubMed ID: 8855366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs.
    Inoue M; Kitazawa T; Cao J; Taneike T
    Eur J Pharmacol; 2003 Feb; 461(2-3):207-18. PubMed ID: 12586216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ; Peroutka SJ
    J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
    Jerning E; Svantesson GT; Mohell N
    Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.
    Borsini F; Giraldo E; Monferini E; Antonini G; Parenti M; Bietti G; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):276-82. PubMed ID: 8584042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding characteristics of GYKI-46 903, a non-competitive ligand at 5-HT3 receptors.
    Vitális B; Sebestyén L; Sike M; Sólyom S; Hársing LG
    Pharmacol Res; 2001 Mar; 43(3):291-9. PubMed ID: 11401422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of 5-HT3 receptor binding assay: enhancement of specific [3H]quipazine binding with Triton X-100-treated membranes from rat cortex.
    Une T; Furukawa K; Komiya M
    Jpn J Pharmacol; 1991 Oct; 57(2):197-203. PubMed ID: 1812298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
    Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
    Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding thermodynamics of 5-HT1A receptor ligands.
    Dalpiaz A; Borea PA; Gessi S; Gilli G
    Eur J Pharmacol; 1996 Sep; 312(1):107-14. PubMed ID: 8891585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.